The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Little, A. M.
Right arrow Articles by Parham, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Little, A. M.
Right arrow Articles by Parham, P.

The Journal of Immunology, Vol 154, Issue 10 5205-5215, Copyright © 1995 by American Association of Immunologists


ARTICLES

Dissociation of beta 2-microglobulin from HLA class I heavy chains correlates with acquisition of epitopes in the cytoplasmic tail

AM Little, E Nossner and P Parham
Department of Structural Biology, Stanford University, CA 94305, USA.

A rabbit antiserum "ABR2" was raised against a peptide with sequence identity to 10 amino acids of the cytoplasmic tail of HLA class I heavy chains. Western blotting and immunoprecipitation analyses demonstrate that ABR2 reacts with HLA class I heavy chains. The antiserum reacts poorly with beta 2-microglobulin (beta 2-m)-associated heavy chains and reacts strongly with free heavy chains. ABR2 reacts with immature heavy chains from the endoplasmic reticulum that have yet to bind beta 2-m and mature heavy chains that have dissociated from beta 2-m at the plasma membrane. Comparison with HC10, a mAb that recognizes an epitope defined by polymorphism at residue 62 of the alpha 1 helix of free HLA class I heavy chains, shows that ABR2 reacts with overlapping populations of free heavy chains (for those allotypes that react with both Abs), but it also identifies populations that bind to one Ab and not the other. ABR2 induces dissociation of beta 2-m from HLA-B38 molecules expressed by the human B cell line "TEM," a phenomenon not detected with other allotypes or with the same allotype in a different cell line. This study shows that association of beta 2-m with the extracellular domains of HLA class I heavy chains can cause a change in the cytoplasmic tail that prevents binding of Abs present in the ABR2 antiserum. Similar findings have been made for mouse H-2 class I molecules, which suggests that this is a general property of class I MHC molecules.


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. J. Ladasky, S. Boyle, M. Seth, H. Li, T. Pentcheva, F. Abe, S. J. Steinberg, and M. Edidin
Bap31 Enhances the Endoplasmic Reticulum Export and Quality Control of Human Class I MHC Molecules
J. Immunol., November 1, 2006; 177(9): 6172 - 6181.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Perosa, G. Luccarelli, M. Prete, E. Favoino, S. Ferrone, and F. Dammacco
{beta}2-Microglobulin-Free HLA Class I Heavy Chain Epitope Mimicry by Monoclonal Antibody HC-10-Specific Peptide
J. Immunol., August 15, 2003; 171(4): 1918 - 1926.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Bodnar, Z. Bacso, A. Jenei, T. M. Jovin, M. Edidin, S. Damjanovich, and J. Matko
Class I HLA oligomerization at the surface of B cells is controlled by exogenous {beta}2-microglobulin: implications in activation of cytotoxic T lymphocytes
Int. Immunol., March 1, 2003; 15(3): 331 - 339.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Watanabe, K. E. Magor, and P. Parham
Exon 5 Encoding the Transmembrane Region of HLA-A Contains a Transitional Region for the Induction of Nonsense-Mediated mRNA Decay
J. Immunol., December 15, 2001; 167(12): 6901 - 6911.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Porgador, O. Mandelboim, N. P. Restifo, and J. L. Strominger
Natural killer cell lines kill autologous beta 2-microglobulin-deficient melanoma cells: Implications for cancer immunotherapy
PNAS, November 25, 1997; 94(24): 13140 - 13145.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.